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Cardiac protection
Kidney protectionThe mechanism underlying remote ischemic preconditioning is
yet to be elucidated, although animal studies have implicated
either a humoral or neuronal pathway as the mediator of organ
protection. Preconditioning of rat mesenteric or renal arteries and
pig hind limb has been shown to reduce cardiac and acute
pulmonary injury [1,2], and remote preconditioning has been
shown to reduce endothelial dysfunction and inﬂammatory cell
activation in humans [3]. Cheung et al. described the ﬁrst clinical
application of remote preconditioning in humans [4]. In their
randomized, controlled trial, Cheung et al. induced remote
preconditioning of lower limb ischemia in children undergoing
cardiac surgery, and found that it reduced postoperative inotropic
requirements, myocardial injury, and airway resistance. Ali et al.
conducted a randomized trial in which they investigated whether
remote ischemic preconditioning would reduce the incidence of
myocardial and renal injury in patients undergoing elective open
abdominal aortic aneurysm repair, and the results showed that it
reduced the incidence of myocardial injury, myocardial infarction,
and renal impairment [5]. They found that the beneﬁcial effects of
preconditioning in the abdominal aortic aneurysm patients were
predominant 24 h after surgery, and speculated that its protective
effects were the results of the effect of early phase preconditioning
(involving numerous mediators, triggers, and signaling pathways
that included adenosine, bradykinin, opiates, kinases, and adeno-
sine triphosphate-dependent potassium channels) on prolonged
stress-induced ischemia. Although early randomized studies
reported reduced troponin release in patients undergoing coronary
artery bypass surgery, these organ protecting effects were
replicated in some but not all prospective randomized controlled
trials [6,7]. The inconsistent results may have been attributed to
differences in study protocols, i.e. differences in variable cycle
length, number of cycles, choice of remote limb (upper limb, lower
limb, or both), confounding comorbidities, anesthetic regimens
(propofol or volatile anesthetics), analgesic (opioid) substance,
treatment with antidiabetic sulfonylureas, surgical procedures,
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patients undergoing mitral valve replacement surgery under
different remote ischemic preconditioning protocols [8]. They
concluded that because the groups of patients who underwent
remote ischemic preconditioning by some of the protocols had a
signiﬁcantly lower postoperative inotropic requirement and levels
and signiﬁcantly lower postoperative serum cardiac troponin I
levels, remote ischemic preconditioning has some degree of
protective effect clinically. Interestingly, they observed positive
effect of remote ischemic preconditioning not in the control
patients or in the patients who had undergone upper arm ischemia
but in the patients with both upper arm and lower limb ischemia.
Xie et al. reported ﬁnding that remote ischemic preconditioning of
the arm alone reduced the serum troponin I concentration and
improved the cardiac function of patients undergoing mitral valve,
aortic valve, or tricuspid valve surgery [9]. Choi et al. investigated
the postoperative effects of remote ischemic preconditioning
performed in patients undergoing complex valvular heart surgery
[10]. They observed no signiﬁcant differences in the serum levels of
biomarkers of renal injury or the incidence of acute kidney injury
between the remote ischemic preconditioning group and control
group, but the serum creatine kinase isoenzyme MB at 24 h after
surgery was lower, and the length of stay in the intensive care unit
shorter in the remote ischemic preconditioning group than in the
control group. They concluded that remote ischemic precondition-
ing did not reduce the degree of renal injury or incidence of acute
renal injury in patients undergoing complex valvular surgery, but
that it did reduce myocardial injury.
In the present study, Pineau et al. conducted a randomized
controlled study to evaluate the effectiveness of remote ischemic
preconditioning on aortic valve surgery patients [11]. The patients
were assigned prospectively and randomly, and after induction of
anesthesia a cuff inﬂatorwas used to perform three cycles of 5-min
inﬂation to 200 mmHg and 5-min deﬂation in the remote ischemic
preconditioning. Theymeasured cardiac troponin I, creatine kinase
isoenzyme MB, the incidence of acute kidney injury, extubation
time, intensive care unit stay, and Simpliﬁed Acute Physiology
Score II, but because there were no signiﬁcant differences in any of
these parameters between the two groups, they concluded that
remote ischemic preconditioning did not have signiﬁcant cardiac
or kidney protective effects in patients undergoing isolated aortic
valve replacement. The authors are congratulated as while the
remote ischemic preconditioning effects had been mainly focused
on the coronary artery bypass graft surgery, they focused on the
effects of remote ischemic preconditioning on isolated aortic valve
surgery. As the authors describe in the discussion, propofol thatgy.
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used, and patients with diabetes who may be treated with
sulfonylurea medications which inhibit adenosine triphosphate-
sensitive potassium-channel conductance that impede the remote
ischemic preconditioning were included in this study, further
research is needed, and a large randomized studywith a robust and
relevant clinical end point is called for. Recently, as an initial step to
understand precise clinical organ protective effects, Zarbock et al.
performed a multicenter, randomized, controlled, clinical trial to
investigate the organ protective effect of remote ischemic
preconditioning in cardiac surgery patients at high risk for acute
kidney injury after on-pump cardiac surgery [12]. The subjects of
their study were 240 patients with a Cleveland Clinic Foundation
score of 6 or higher to deﬁne patients at high risk for acute kidney
injury. The exclusion criteria were acute myocardial infarction
within 7 days before surgery, preexisting acute kidney injury,
kidney transplantation, chronic kidney disease with a glomerular
ﬁltration rate less than 30 ml/min, pregnancy, peripheral vascular
disease affecting the upper limbs, hepatorenal syndrome, and drug
therapy with a sulfonamide (preconditioning-blocking drug) and/
or nicorandil (preconditioning-mimetic drug). Anesthesia was
maintained with volatile anesthetics without propofol, and
cardiopulmonary bypass management was standardized. The
remote ischemic preconditioning consisted of three cycles of
inﬂation of a blood pressure cuff on one upper arm. Comparison of
the results with the control group showed that acute kidney injury
was signiﬁcantly reduced by the remote ischemic preconditioning,
and fewer patients who underwent remote ischemic precondi-
tioning received renal replacement therapy. The remote ischemic
preconditioning also reduced intensive care unit stay, but there
was no signiﬁcant effect on the myocardial infarction, stroke, or
mortality rates. Remote ischemic preconditioning resulted in
signiﬁcant postoperative decreases in the release of urinary
insulin-like growth factor-binding protein 7 and tissue inhibitor
of metalloproteinases 2. Based on these results, Zarbock et al.
concluded that remote ischemic preconditioning signiﬁcantly
reduced the rate of acute kidney injury and use of renal
replacement therapy and that suchmeasureswould be particularly
desirable to deal with the increasingly challenging risk proﬁles of
patients who are referred for cardiac surgery. Zarbock et al.
conducted a detailed, well-designed study that investigated acute
kidney injury in patients undergoing cardiac surgery, and they
succeeded in identifying speciﬁc beneﬁts of remote ischemic
preconditioning.
Accumulating such focused studies will provide new insights
into the heterogeneity of the therapeutic effects of remote
ischemic preconditioning observed across previous studies and
make it possible to identify the mechanism by which it exerts its
protective effects.References
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